期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
慢性心力衰竭患者Arg389Gly基因多态性与改善心室重塑及临床预后的关系 被引量:3
1
作者 杨丹 黄宇理 徐淑楠 《中华全科医学》 2023年第2期221-224,349,共5页
目的 探讨β1肾上腺素受体Arg389Gly基因多态性与慢性心力衰竭患者心功能变化情况及临床预后的关系。方法 选取2020年4月-2021年5月蚌埠医学院第一附属医院的慢性心力衰竭患者120例,根据Arg389Gly基因型将患者分成CC组(43例)、GC组(56例... 目的 探讨β1肾上腺素受体Arg389Gly基因多态性与慢性心力衰竭患者心功能变化情况及临床预后的关系。方法 选取2020年4月-2021年5月蚌埠医学院第一附属医院的慢性心力衰竭患者120例,根据Arg389Gly基因型将患者分成CC组(43例)、GC组(56例)、GG组(21例)3组。收集患者入院时的临床资料,出院后通过门诊或电话对其进行6个月的随访,分析3组患者药物治疗前后心功能变化情况及临床预后。结果 Arg389Gly基因型频率分别为35.8%(CC)、46.7%(GC)、17.5%(GG);随访6个月后,3组患者在氨基末端脑钠肽前体(NT-proBNP)降幅、左心室射血分数(LVEF)升幅及左心室舒张末期内径(LVDD)、左心室收缩末期内径(LVDS)降幅上的差异均有统计学意义(均P<0.05),且CC组的改善情况显著优于GG组(P<0.017);3组患者的可溶性生长刺激表达基因2蛋白(sST2)降幅在随访至6个月时其差异有统计学意义(P=0.006),且CC组优于GG组(P=0.014)。在随访过程中出现了心源性死亡、因心力衰竭再入院、恶性心律失常事件的患者共44例,log-rank检验提示3组患者终点事件发生率的差异有统计学意义(P=0.026),Kaplan-Meier曲线提示CC组终点事件的发生率低于GG组。结论 Arg389Gly基因多态性与慢性心力衰竭患者的心功能变化及临床预后有关。 展开更多
关键词 心力衰竭 arg389gly基因 基因多态性 心室重塑 预后
暂未订购
南昌地区心血管疾病患者ADRB1 Arg389Gly基因多态性研究 被引量:1
2
作者 朱月 赖祥德 易金萍 《现代诊断与治疗》 CAS 2024年第10期1423-1426,共4页
目的探讨南昌地区心血管疾病患者人群ADRB1 Arg389Gly基因的分布情况及地域性和种族差异。方法选取2020年7月至2022年1月于南昌大学第一附属医院住院治疗的590名心血管疾病患者为研究对象,应用TaqMan技术对ADRB1 Arg389Gly基因进行分型... 目的探讨南昌地区心血管疾病患者人群ADRB1 Arg389Gly基因的分布情况及地域性和种族差异。方法选取2020年7月至2022年1月于南昌大学第一附属医院住院治疗的590名心血管疾病患者为研究对象,应用TaqMan技术对ADRB1 Arg389Gly基因进行分型鉴定,分析不同性别、不同年龄、不同疾病人群ADRB1 Arg389Gly基因表达情况,并将南昌地区与已报道的不同地区基因表达情况进行比较。结果ADRB1 Arg389Gly基因分型结果符合Hardy-Weinberg平衡;南昌地区心血管疾病患者ADRB1 Arg389Gly基因型频率,在不同年龄人群中≥65岁GG基因型患者明显多于<65岁患者,差异有统计学意义(P<0.05);在不同疾病人群中AS组GC基因型频率明显少于NAS组差异有统计学意义(P<0.05);其他基因型及等位基因频率无显著差异(P>0.05);南昌地区与阿拉伯等七个地区基因型及等位基因频率比较,差异有统计学意义(P<0.05);与淮安、上海、南印度地区基因型及等位基因频率比较,无显著差异(P>0.05)。结论南昌地区人群ADRB1 Arg389Gly基因符合Hardy-Weinberg平衡。ADRB1 Arg389Gly基因在南昌地区不同人群中的表达不一致,并且存在地域性和种族差异。 展开更多
关键词 ADRB1 arg389gly 心血管疾病 基因多态性
暂未订购
ADRB1 Arg389Gly多态性对比索洛尔疗效影响的Meta分析
3
作者 张天齐 李婷 +2 位作者 张田 赵紫楠 纪立伟 《中国药房》 CAS 北大核心 2024年第5期601-606,共6页
目的探索ADRB1 Arg389Gly多态性对比索洛尔疗效的影响,为比索洛尔个体化药物治疗提供参考。方法从PubMed、Embase、Cochrane Library、中国生物医学文献服务系统、中国知网、万方等数据库系统性搜索与比索洛尔和ADRB1 Arg389Gly多态性... 目的探索ADRB1 Arg389Gly多态性对比索洛尔疗效的影响,为比索洛尔个体化药物治疗提供参考。方法从PubMed、Embase、Cochrane Library、中国生物医学文献服务系统、中国知网、万方等数据库系统性搜索与比索洛尔和ADRB1 Arg389Gly多态性相关的文献,检索时间为建库至2023年5月。根据研究制定的纳入与排除标准筛选、提取相关文献并进行文献质量评估。使用RevMan 5.4软件对相关结局指标进行Meta分析。结果最终纳入7项研究,共计1339人次。其中4项研究涉及比索洛尔治疗前后收缩压(SBP)和舒张压(DBP)的变化量(ΔSBP和ΔDBP),有4项研究涉及治疗前后左室射血分数(LVEF)的变化量(ΔLVEF)。研究结果显示,比索洛尔对ADRB1 Arg389Gly野生组(AA)和突变组(AG+GG)血压改善的差异均无统计学意义{ΔSBP[SMD=0.17,95%CI(-0.97,1.31),P=0.77]、ΔDBP[SMD=-0.01,95%CI(-0.65,0.62),P=0.97]};比索洛尔对两组ΔLVEF改善的差异亦无统计学意义[SMD=-0.61,95%CI(-2.74,1.53),P=0.58]。结论ADRB1 Arg389Gly多态性对比索洛尔改善心血管患者SBP、DBP和LVEF的作用无显著影响。 展开更多
关键词 比索洛尔 β_(1)肾上腺素受体 ADRB1 arg389gly 基因多态性 META分析
暂未订购
β_1-adrenergic receptor(Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure
4
作者 俞文萍 《China Medical Abstracts(Internal Medicine)》 2006年第4期193-194,共2页
Objective The purpose of this study was to investigate the relation between the Arg389Gly polymorphism of theβ1-AR gene and chronic heart failure (CHF) and to evaluate the effect of this polymorphism on clinical resp... Objective The purpose of this study was to investigate the relation between the Arg389Gly polymorphism of theβ1-AR gene and chronic heart failure (CHF) and to evaluate the effect of this polymorphism on clinical response toβ-adrenoceptor blockade (bisoprolol) in patients with CHF. Methods One hundred and ten patients with stable CHF receiving basic therapy for heart failure were included. Before initiation and 3 months af- 展开更多
关键词 ADRENERGIC arg389gly hundred LVESD LVEDD receiving INITIATION MORPHISM substantially eater
原文传递
ADRB1基因多态性与收缩性心力衰竭相关性研究 被引量:6
5
作者 洪暄 余珊珊 +3 位作者 陈明 范慧敏 刘中民 康晟 《山西医科大学学报》 CAS 2015年第3期202-207,共6页
目的探索β1-肾上腺素能受体(ADRB1)Arg389>Gly多态性与收缩性心力衰竭(SHF)患病风险是否独立相关。方法采用回顾性病例对照研究,获得1 716名受试者的基因血测序数据(sanger method),同时取得相关临床实验室检测、心电图和超声心动... 目的探索β1-肾上腺素能受体(ADRB1)Arg389>Gly多态性与收缩性心力衰竭(SHF)患病风险是否独立相关。方法采用回顾性病例对照研究,获得1 716名受试者的基因血测序数据(sanger method),同时取得相关临床实验室检测、心电图和超声心动图检查的结果,并根据左室射血分数(LVEF)小于50%或二维超声心动图多节段的室壁收缩运动减低分为SHF组和无SHF组,观察ADRB1 Arg389Gly多态性、NT-pro BNP、LVEF等指标。结果在无SHF人群中,ADRB1 Arg389和Gly389等位基因频数(频率)分别为2 127(0.715)和849(0.285)(χ2=0.272,P>0.05),SHF人群的Arg389和Gly389的等位基因频数(频率)分别为331(0.726)和125(0.274)(χ2=1.892,P>0.05)。简单相关分析表明ADRB1基因多态性(Arg389Arg,Arg389Gly和Gly389Gly)与LVEF、NT-pro BNP和SHF之间无显著性相关(r分别为-0.004、0.007和0.007,P均>0.05)。进一步通过Logistic回归模型,调整心力衰竭的相关危险因素后,与基线Arg389Arg相比,ADRB1突变体与SHF患病风险无显著性独立相关(P均>0.05)。结论 ADRB1 Arg389Gly多态性与SHF患病风险无独立的相关性。 展开更多
关键词 ADRB1 Arg389〉Gly多态性 等位基因频率 收缩性心力衰竭
暂未订购
Association between essential hypertension and polymorphisms of beta 1 adrenergic receptor gene G1165C (Gly389Arg) in Chinese Mongolian population 被引量:2
6
作者 Rile Hu Rile Hu +4 位作者 Shigang Zhao Guangming Niu Chunyu Zhang Zhiguang Wang Mingfang Jiang 《Neural Regeneration Research》 SCIE CAS CSCD 2006年第3期226-229,共4页
BACKGROUND: The prevalences of hypertension, cerebrovascular diseases, etc. are higher in Mongolian population because of the influence of various factors including genetics, geography, diet, etc. Therefore, it is he... BACKGROUND: The prevalences of hypertension, cerebrovascular diseases, etc. are higher in Mongolian population because of the influence of various factors including genetics, geography, diet, etc. Therefore, it is helpful to develop researches on the genetics of various diseases including hypertension in Mongolian population. OBJECTIVE: To analyze the association between the polymorphism of beta1 adrenergic receptor (β1-AR) gene G1165C (Arg389Gly), an important candidate gene for various diseases of cardiovascular system, and essential hypertension in Mongolian population. DESIGN : A cross-sectional study SETTINGS: Department of Neurology, the First Affiliated Hospital of Inner Mongolia Medical College; Wulate Houqi Red Cross Society. PARTICIPANTS: The survey was carried out from February 2003 to March 2005. Totally 239 Mongolian residents, whose blood relations of 3 generations were all Mongolians, were selected from Wulate Houqi, Inner Mongolia, and they were all informed with the survey and detected items. Based on the diagnostic standard of hypertension set by WHO in 1999, the subjects were divided into two groups according to the level blood pressure: ① Normal blood pressure group (n=117): systolic blood pressure (SBP) 〈 140 mm Hg (1 mm Hg =0.133 kPa), diastolic blood pressure (DBP) 〈 90 mm Hg, and those having histories of cerebrovascular disease, heart disease, diseases of liver, kidney and tiroides, and diabetes mellitus were excluded. ② Essential hypertension group (n=122): including 51 patients with simple high SBP. All the enrolled subjects had no blood relationship with each other, and had no history of miscegenation. METHODS : The body height, body mass, waist circumference and blood lipids were measured routinely, and their habits of smoking and drinking were also investigated. Penpheral venous blood (5 mL) was drawn, the genome DNA was extracted, and the polymorphisms of the β1-AR Gl165C (Gly389Arg) genotype were detected with the Sequenom system. Polymerase chain reaction (PCR) experiment and SNP detection were performed in Huada Gene Laboratory of Bejing, then the univariate analysis of variance was applied in the sample comparison among groups, and the chi-square test was used to compare the genotypes and allele frequencies. The odd ratio (OR) and 95% confidence interval (CO were calculated. MAIN OUTCOME MEASURES: The distributions of β1-AR Gl165C (Gly389Arg) genotypes and alleles were observed. RESULTS: A11 the 239 subjects were involved in the analysis of results, and no one missed, ①Comparison of β1-AR G1165C (Gly389Arg) genotypes and allele distnbutions: In Mongolian population, the frequencies of CC and GG+GC genotypes at β1-AR G1165C (Gly389Arg) site in the essential hypertension group (72%, 28%) were not significantly different from those in the normal blood pressure group (67%, 33%) (xz=0.841, P=-0.359; OR 0.773, 95%Cl: 0.445-1.342); The frequencies of C and G alleles also had no significant differences between the essential hypertension group (85%, 15%) and the normal blood pressure group (82%, 18%) (x^2=1.136, P=-0.287; OR: 0.769, 95%Cl: 0.747-1.248). ②The frequencies of CC and GG+GC genotypes at β1-AR G1165C (Gly389Arg) site had no significant differences between the patients with simple high SBP (71%, 29%) and the normal blood pressure group (x^2=0.250, P=-0.617; OR: 0.833, 95%C/: 0.408-1.703); The frequencies of C and G alleles were not significantly different between the patients with simple high SBP (86%, 14%) and the normal blood pressure group (x^2=0.670, P=-0.413; OR 0.766, 95%Cl: 0.404-1.453). CONCLUSION: In Mongolian population, the distributions of the genotypes and alleles of β1-AR Gl165C (Gly389Arg) have no obvious differences between the subjects with normal blood pressure and the patients with essential hypertension (including simple SBP increase), which suggests that G1165C (Glu389Asp) site of β1-AR gene may be not a genetic mark of essential hypertension and simple high SBP in Mongolian population. 展开更多
关键词 Gly389Arg Association between essential hypertension and polymorphisms of beta 1 adrenergic receptor gene G1165C in Chinese Mongolian population gene
暂未订购
ADRB1389位点基因多态性对美托洛尔疗效影响的meta分析 被引量:2
7
作者 窦晓涛 刘涛 +2 位作者 王浩宇 周倩 刘冰洁 《现代医药卫生》 2020年第21期3414-3419,共6页
目的探究β1肾上腺素受体389位点(rs 1801253)的基因多态性对美托洛尔疗效的影响。方法从中国知网、万方、维普、Embase、SCIE、PubMed等数据库检索从建库至今发表的关于ADRB1389位点基因多态性与美托洛尔有关的文献,通过纳入及排除标... 目的探究β1肾上腺素受体389位点(rs 1801253)的基因多态性对美托洛尔疗效的影响。方法从中国知网、万方、维普、Embase、SCIE、PubMed等数据库检索从建库至今发表的关于ADRB1389位点基因多态性与美托洛尔有关的文献,通过纳入及排除标准筛选文献,并进行文献质量评价、提取数据,使用RevMan 5.3软件进行定量meta分析。结果最终纳入5篇文献,基因型分布包括:317例Gly389携带者(GG+GC),250例Arg389纯合突变型(CC)。在收缩压控制方面,美托洛尔在CC中疗效优于GG+GC(P=0.01),而突变杂合型GC与野生型GG之间无统计学差异(P=0.77);在舒张压控制方面,CC人群美托洛尔疗效显著优于GG+GC(P=0.0003),而GG与GC之间无统计学差异(P=0.68);在心率控制方面,CC人群美托洛尔疗效同样显著优于GG+GC(P=0.0006),而GC与GG之间无统计学差异(P=0.49)。结论不同的ADRB1389位点基因型对美托洛尔疗效有显著影响,且美托洛尔在CC人群中有更好的疗效,而GG和GC两基因型对美托洛尔疗效的影响无明显差异。 展开更多
关键词 Β1肾上腺素受体 ADRB1 Gly389Arg 基因多态性 美托洛尔 META分析
暂未订购
β1肾上腺素受体Gly389Arg基因多态性对美托洛尔心血管效应的影响
8
作者 刘洁 刘昭前 《中国药理通讯》 2002年第4期61-61,共1页
关键词 Β1肾上腺素受体 Gly389Arg 基因多态性 美托洛尔心血管效应
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部